Self-management and the chronic disease epidemic
Chronic diseases are the leading causes of mortality, accounting for 60% of all deaths worldwide 1 .
Driven by an aging population, demographic trends, future life-style patterns and changes in diagnostics, future projections indicate that the burden of chronic disease will substantially increase over the next decennia 2;3 . The number of patients suffering from multiple chronic conditions will show a proportionally large increase. The burden of meeting the needs of this growing number of people will fall upon already over-stretched health care services that are struggling to cope with the demands of acute care let alone the needs of those with long-term health condition 4 . As a result, there has been a shift away from paternalistic models of health care that sited the patient in the role of passive recipient towards more active involvement of patients in dealing with the day-to-day realities of chronic disease 5 . A promising approach to improving outcomes and reducing health care costs associated with chronic conditions is "self-management," whereby individuals, in collaboration with health-care professionals, assume greater responsibility for health care decisions 5 . Selfmanagement is one of the four major components of the Chronic Care Model and involves both the community and the health-care system 6 . It presupposes that when "Informed Activated Clients" interact with a "Prepared, Proactive, Practice Team," the results are improved functional and clinical It is important to understand the difference between self-management support and patient education, given that these terms are often mistakenly used synonymously. The goals of selfmanagement support are different from of patient education. Patient education refers to traditional, largely didactic, instruction provided to patients which focuses mainly on transfer of knowledge. Selfmanagement support is defined as the systematic provision of supportive interventions by health care staff to increase patients' skills and confidence in managing their health problems, including regular assessment of progress and problems, goal setting, and problem-solving support 7 . Although self-management interventions often also contain didactic strategies, the pivotal objective is to change behavior, which is essential to boot a sequence of effects 8 . Improved self-management behavior is expected to lead to better disease control which should, in turn, lead to better patient outcomes, reduced use of health care services and ultimately to reduced costs and increased patient satisfaction. Core self-management behavioral skills are problem solving, decision making, effective resource utilization, forming of a patient/health care provider partnership, and taking action 9 .
Self-management: is it effective?
Over the past decade self-management programs have been developed with good progress and a gradually increasing body of evidence. Table 1 illustrates the pooled evidence from meta-analyses emerging, which indicates that self-management in patients with, asthma 10 , chronic heart failure 11 , COPD 12 , diabetes type-2 (DM-II) 13 , hypertension 14 , musculoskeletal pain 15 and patients on oral anticoagulation 16 improves a variety of outcomes such as improved disease-specific outcomes, quality of life, self-management behavior, and reduced healthcare costs. Given these encouraging results one might conclude that nothing should prevent policy makers and healthcare professionals from robust implementation of self-management in routine care. Although improving patients' selfmanagement skills apparently seems meaningful and harmless, in 2012 alone three large trials reported negative 17 or even adverse outcomes including unexplained higher mortality rates 18;19 (one mainly focusing at telemonitoring). This might indicate that self-management interventions are not necessarily harmless. Should this temper our enthusiasm for self-management support? Forest plots in meta-analyses seem to favor self-management, yet it is important to realize that available trials are characterized by large heterogeneity in self-management approaches in terms of mode, dose, intensity, delivery, etc., resulting in large variance in effect sizes. This substantially hampers our understanding of the effectiveness of self-management.
Self-management: what works best?
Several meta-analysis have attempted to evaluate possible shifts in effect size for different program characteristics but were largely unrevealing 11;13;14;20 . However, in patients with COPD 9 and asthma 11 the addition of action plans for self-treatment of exacerbations is associated with a somewhat larger reduction in healthcare utilization. In DM-II, improvements in glycaemic control seem more pronounced when psychosocial behavioral techniques are used 20;21 . The addition of self-adjusted therapy in patients on oral coagulation seems dominant compared to self-monitoring alone in terms of a slightly greater reduction in thromboembolic events and mortality 16 . 
One size does not fit all: urge for tailored interventions
A self-management program is not equal to prescribing patients a drug but instead a classic example of a 'complex intervention' -a treatment strategy containing several interacting components and varying dimensions of complexity (i.e. variability in delivery, organizational levels, outcomes, etc.) 22 .
When applied to subtly different target populations or healthcare settings these interventions can produce substantially variable results. Although we can conclude that self-management is effective in mean group-outcomes, individual trials report that a substantial proportion of patients do not comply or do not respond to these interventions. The large variance in effect size between patients presumes that 'one size does not fit all'. So far, little is known on factors distinguishing compliers and responders from non-compliers and non-responders. It is still unknown whether in this group a subtle change in the components, mode or intensity of a self-management intervention would have been sufficient to optimize outcomes. It is likely that for a selection of patients some selfmanagement assistance is already sufficient in adequately controlling their disease, while other patients only benefit from more intense self-management support, case-management or even passive surveillance (monitoring). Furthermore, it is plausible that a selection of patients particularly benefit from face-to-face contacts, while sophisticated E-health solutions are suitable for other patients. Given the fact that not all patients seem to benefit from current 'one size fits all' interventions, effect size might substantially be increased by tailoring programs to the individual.
Increased knowledge on the program-and patient-related facilitators and barriers of success of selfmanagement interventions can facilitate the development of tailored interventions based on individual patient profiles and preferences.
Conclusion and future directions
Self-management for people with chronic diseases is now widely recognized as an essential part of 
